HCM - HUTCHMED DRC - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

HCM is currently covered by 2 analysts with an average price target of $26.81. This is a potential upside of $10.5 (64.38%) from yesterday's end of day stock price of $16.31.

HUTCHMED DRC's activity chart (see below) currently has 12 price targets and 14 ratings on display. The stock rating distribution of HCM is 33.33% BUY and 66.67% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 64.58% with an average time for these price targets to be met of 303.25 days.

Highest price target for HCM is $19, Lowest price target is $15, average price target is $34.5.

Most recent stock forecast was given by PAUL CHOI from on 01-Aug-2024. First documented stock forecast 11-Apr-2016.

Best performing analysts who are covering HCM - HUTCHMED DRC:

Ranjan Sharma Paul Choi Louise Chen Heather Balsky

Currently out of the existing stock ratings of HCM, 1 are a BUY (33.33%), 2 are a HOLD (66.67%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$19

$2.69 (16.49%)

$17

1 years 8 days ago
(01-Aug-2024)

5/6 (83.33%)

$0.52 (2.81%)

140

Buy

$50

$33.69 (206.56%)

$50

1 years 11 months 4 days ago
(05-Sep-2023)

1/4 (25%)

$35.15 (236.70%)

477

Buy

$11

$-5.31 (-32.56%)

$11

2 years 29 days ago
(11-Jul-2023)

1/2 (50%)

$-1.31 (-10.64%)

187

Buy

$20

$4.85 (32.01%)

$40

3 years 3 months 5 days ago
(04-May-2022)

2/2 (100%)

$7.62 (61.55%)

409

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is HCM (HUTCHMED DRC) average time for price targets to be met?

On average it took 303.25 days on average for the stock forecasts to be realized with a an average price target met ratio 64.58

Which analyst has the current highest performing score on HCM (HUTCHMED DRC) with a proven track record?

RANJAN SHARMA

Which analyst has the current lower performing score on HCM (HUTCHMED DRC) with a proven track record?

HEATHER BALSKY

Which analyst has the most public recommendations on HCM (HUTCHMED DRC)?

Ranjan Sharma works at JPMORGAN and has 6 price targets and 3 ratings on HCM

Which analyst is the currently most bullish on HCM (HUTCHMED DRC)?

Louise Chen with highest potential upside - $33.69

Which analyst is the currently most reserved on HCM (HUTCHMED DRC)?

Heather Balsky with lowest potential downside - -$5.31

HUTCHMED DRC in the News

HUTCHMED Reports 2025 Interim Results

HUTCHMED (China) Limited — Indications expansion driving growth and ATTC platform enriching pipeline — — $455 million in net income attributable to HUTCHMED driven by non-core partial disposal — HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Aug. 07, 2025 (GLOBE NEWSWIRE) — HUTCHMED (China) Limited (“HUTCHMED”, the “Company” or “we”) (Nasdaq/AIM:​HCM; HKEX:​13) today reports its financial...

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?